USPTO serial 99831322
XUANMU
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- DONEGAN, DANIEL P
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with XUANMU?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*
Plus Government fees of $150
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Guiping Liang
5F, West Building, Julong Complex,No.9 Hangda Rd., Xihu Dist.,Hangzhou, 310007Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for the prevention and treatment of cancer; Therapeutic pharmaceutical for the treatment of invasive aspergillosis and invasive mucormycosis in adult patients; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Antifungal preparations; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of hyperlipidemia; Antimicrobial preparations for treating invasive aspergillosis and invasive mucormycosis in adult patients; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of invasive aspergillosis and invasive mucormycosis in adult patients; Biostatic antimicrobial preparations for treating bacteria, mold, mildew, algae and yeast and for inhibiting growth of those organisms; Pharmaceutical products for treating respiratory diseases; Cardiovascular agents for medical purposes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Fungal medications; Inhalants for the treatment of respiratory conditions; Anti-infectives for human use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Hangzhou Xuanmu Pharmaceutical Co., Ltd.
- Other trademarks owned by Hangzhou Xuanmu Pharmaceutical Co., Ltd.
- Other trademarks in Class 005
- Similar marks named XUANMU
- Prosecution event NOAM explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 27, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 1, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 1, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 26, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 6, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 28, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| May 19, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 19, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 19, 2026 | NWAP | NEW APPLICATION ENTERED | — |